COVID-19 Mitigation Products Market - 2024-2031
The COVID-19 Mitigation Products Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A COVID-19 Mitigation Products Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Diagnostic Products and Services
Both primary and secondary data sources have been used in the global COVID-19 Mitigation Products Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
A COVID-19 Mitigation Products Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Diagnostic Products and Services
- Serologic Test Kits*
- Robotic PCR Systems & Software
- PCR Instrumentation & Software
- Nose & Mouth Swabs
- PCR Reagents & Consumables
- Self-collection PCR Test Kits
- X-Ray Procedures
- Others
- Invasive Mechanical Ventilators *
- Noninvasive Ventilators
- Portable Ventilators
- Next Generation Ventilators
- Kidney Dialysis
- Surge Capacity Hospitals & ICUs
- Extracorporeal Membrane Oxygenation Procedures
- Others
- E-Health *
- AI, Big Data & Deep Learning
- Blockchain Technologies
- Geo-Surveillance Systems & Services
- Homecare IT
- Others
- Vaccines*
- Therapeutic Drugs
- Others
- Medical Gloves *
- Medical Face Masks
- Medical PPE Gowns
- Hand & Surface Sanitizers
- Medical Face Shields
- PPE Sterilization: Systems & Consumables
- Medical Eye Protection
- Others
- Ventilators*
- Serologic Test Kits
- Self-collection PCR Test Kits
- PCR Reagents
- PCR Systems
- Gloves
- PPE Gowns
- Others
- Hospitals*
- Emergency Medical Services (EMS)
- Clinical Labs
- Research Bodies
- Homecare & Nursing Homes
- Clinics
- Others
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Go-to-market Strategy.
- Neutral perspective on the market performance.
- Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
- Customized regional/country reports as per request and country level analysis.
- Potential & niche segments and regions exhibiting promising growth covered.
- Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Both primary and secondary data sources have been used in the global COVID-19 Mitigation Products Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. SCOPE AND METHODOLOGY
1.1. Research Methodology
1.2. Scope of the Market
2. KEY TRENDS AND DEVELOPMENTS
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Diagnostic Products and Services
3.2. Market Snippet by Intensive Care Products & Services
3.3. Market Snippet by Medical ICT
3.4. Market Snippet by Pharma Industry Products
3.5. Market Snippet by Personal & Protection Gear
3.6. Market Snippet by COVID-19 Related Manufacturing Plant
3.7. Market Snippet by End-User
3.8. Market Snippet by Region
4. MARKET DYNAMICS
4.1. Market impacting factors
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Impact analysis
5. INDUSTRY ANALYSIS
5.1. Porter's five forces analysis
5.2. Value chain analysis
5.3. Patent Analysis
5.4. Regulatory Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
7. BY DIAGNOSTIC PRODUCTS AND SERVICES
7.1. Introduction
7.1.1. Market size analysis, and y-o-y growth analysis (%), By Diagnostic Products and Services Segment
7.1.2. Market attractiveness index, By Diagnostic Products and Services Segment
7.2. Serologic Test Kits*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
7.3. Robotic PCR Systems & Software
7.4. PCR Instrumentation & Software
7.5. Nose & Mouth Swabs
7.6. PCR Reagents & Consumables
7.7. Self-collection PCR Test Kits
7.8. X-Ray Procedures
7.9. Others
8. BY INTENSIVE CARE PRODUCTS & SERVICES
8.1. Introduction
8.1.1. Market size analysis, and y-o-y growth analysis (%), By Intensive Care Products & Services Segment
8.1.2. Market attractiveness index, By Intensive Care Products & Services Segment
8.2. Invasive Mechanical Ventilators *
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
8.3. Noninvasive Ventilators
8.4. Portable Ventilators
8.5. Next Generation Ventilators
8.6. Kidney Dialysis
8.7. Surge Capacity Hospitals & ICUs
8.8. Extracorporeal Membrane Oxygenation Procedures
8.9. Others
9. BY MEDICAL ICT
9.1. Introduction
9.1.1. Market size analysis, and y-o-y growth analysis (%), By Medical ICT Segment
9.1.2. Market attractiveness index, By Medical ICT Segment
9.2. E-Health *
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
9.3. AI, Big Data & Deep Learning
9.4. Blockchain Technologies
9.5. Geo-Surveillance Systems & Services
9.6. Homecare IT
9.7. Others
10. BY PHARMA INDUSTRY PRODUCTS
10.1. Introduction
10.1.1. Market size analysis, and y-o-y growth analysis (%), By Pharma Industry Products Segment
10.1.2. Market attractiveness index, By Pharma Industry Products Segment
10.2. Vaccines*
10.2.1. Introduction
10.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
10.3. Therapeutic Drugs
10.4. Others
11. BY PERSONAL & PROTECTION GEAR
11.1. Introduction
11.1.1. Market size analysis, and y-o-y growth analysis (%), By Personal & Protection Gear Segment
11.1.2. Market attractiveness index, By Personal & Protection Gear Segment
11.2. Medical Gloves *
11.2.1. Introduction
11.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
11.3. Medical Face Masks
11.4. Medical PPE Gowns
11.5. Hand & Surface Sanitizers
11.6. Medical Face Shields
11.7. PPE Sterilization: Systems & Consumables
11.8. Medical Eye Protection
11.9. Others
12. BY COVID-19 RELATED MANUFACTURING PLANT
12.1. Introduction
12.1.1. Market size analysis, and y-o-y growth analysis (%), By COVID-19 Related Manufacturing Plant Segment
12.1.2. Market attractiveness index, By COVID-19 Related Manufacturing Plant Segment
12.2. Ventilators*
12.2.1. Introduction
12.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
12.3. Serologic Test Kits
12.4. Self-collection PCR Test Kits
12.5. PCR Reagents
12.6. PCR Systems
12.7. Gloves
12.8. PPE Gowns
12.9. Others
13. BY END-USER
13.1. Introduction
13.1.1. Market size analysis, and y-o-y growth analysis (%), By End-User Segment
13.1.2. Market attractiveness index, By End-User Segment
13.2. Hospitals*
13.2.1. Introduction
13.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
13.3. Emergency Medical Services (EMS)
13.4. Clinical Labs
13.5. Research Bodies
13.6. Homecare & Nursing Homes
13.7. Clinics
13.8. Others
14. BY REGION
14.1. Introduction
14.1.1. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Region
14.1.2. Market Attractiveness Index, By Region
14.2. North America
14.2.1. Introduction
14.2.2. Key region-specific dynamics
14.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Products and Services
14.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intensive Care Products & Services
14.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pharma Industry Products
14.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medical ICT
14.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Personal & Protection Gear
14.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By COVID-19 Related Manufacturing Plant
14.2.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
14.2.10. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
14.2.10.1. U.S.
14.2.10.2. Canada
14.2.10.3. Mexico
14.3. South America
14.3.1. Introduction
14.3.2. Key Region-Specific Dynamics
14.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Products and Services
14.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intensive Care Products & Services
14.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pharma Industry Products
14.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medical ICT
14.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Personal & Protection Gear
14.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By COVID-19 Related Manufacturing Plant
14.3.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
14.3.10. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
14.3.10.1. Brazil
14.3.10.2. Argentina
14.3.10.3. Rest of South America
14.4. Europe
14.4.1. Introduction
14.4.2. Key Region-Specific Dynamics
14.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Products and Services
14.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intensive Care Products & Services
14.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pharma Industry Products
14.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medical ICT
14.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Personal & Protection Gear
14.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By COVID-19 Related Manufacturing Plant
14.4.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
14.4.10. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
14.4.10.1. Germany
14.4.10.2. U.K.
14.4.10.3. France
14.4.10.4. Spain
14.4.10.5. Italy
14.4.10.6. Rest of Europe
14.5. Asia Pacific
14.5.1. Introduction
14.5.2. Key Region-Specific Dynamics
14.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Products and Services
14.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intensive Care Products & Services
14.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pharma Industry Products
14.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medical ICT
14.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Personal & Protection Gear
14.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By COVID-19 Related Manufacturing Plant
14.5.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
14.5.10. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
14.5.10.1. China
14.5.10.2. India
14.5.10.3. Japan
14.5.10.4. Australia
14.5.10.5. Rest of Asia Pacific
14.6. Middle East and Africa
14.6.1. Introduction
14.6.2. Key Region-Specific Dynamics
14.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Products and Services
14.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intensive Care Products & Services
14.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pharma Industry Products
14.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medical ICT
14.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Personal & Protection Gear
14.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By COVID-19 Related Manufacturing Plant
14.6.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
15. COMPETITIVE LANDSCAPE
15.1. Competitive scenario
15.2. Competitor strategy analysis
15.3. Market positioning/share analysis
15.4. Mergers and acquisitions analysis
16. COMPANY PROFILES
16.1. 3M Company*
16.1.1. Company Overview
16.1.2. Product Portfolio and Description
16.1.3. Key Highlights
16.1.4. Financial Overview
16.2. Abbott
16.3. Agilent Technologies
16.4. Medtronic
16.5. Pfizer
16.6. Qualaris Healthcare Solutions
16.7. Allscripts Healthcare Solutions
16.8. Agfa Healthcare
16.9. AbCellera
16.10. 3Scan
16.11. Sanofi
16.12. Advenio Technosys
16.13. Siemens
16.14. Amara Health Analytics
16.15. Regeneron Pharmaceuticals
16.16. Avalon
16.17. Eli Lilly
16.18. Merck
16.19. Koninklijke Philips NV(*List not Exhaustive*)
17. DATAM INTELLIGENCE
17.1. Appendix
17.2. About us and services
17.3. Contact us
1.1. Research Methodology
1.2. Scope of the Market
2. KEY TRENDS AND DEVELOPMENTS
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Diagnostic Products and Services
3.2. Market Snippet by Intensive Care Products & Services
3.3. Market Snippet by Medical ICT
3.4. Market Snippet by Pharma Industry Products
3.5. Market Snippet by Personal & Protection Gear
3.6. Market Snippet by COVID-19 Related Manufacturing Plant
3.7. Market Snippet by End-User
3.8. Market Snippet by Region
4. MARKET DYNAMICS
4.1. Market impacting factors
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Impact analysis
5. INDUSTRY ANALYSIS
5.1. Porter's five forces analysis
5.2. Value chain analysis
5.3. Patent Analysis
5.4. Regulatory Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
7. BY DIAGNOSTIC PRODUCTS AND SERVICES
7.1. Introduction
7.1.1. Market size analysis, and y-o-y growth analysis (%), By Diagnostic Products and Services Segment
7.1.2. Market attractiveness index, By Diagnostic Products and Services Segment
7.2. Serologic Test Kits*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
7.3. Robotic PCR Systems & Software
7.4. PCR Instrumentation & Software
7.5. Nose & Mouth Swabs
7.6. PCR Reagents & Consumables
7.7. Self-collection PCR Test Kits
7.8. X-Ray Procedures
7.9. Others
8. BY INTENSIVE CARE PRODUCTS & SERVICES
8.1. Introduction
8.1.1. Market size analysis, and y-o-y growth analysis (%), By Intensive Care Products & Services Segment
8.1.2. Market attractiveness index, By Intensive Care Products & Services Segment
8.2. Invasive Mechanical Ventilators *
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
8.3. Noninvasive Ventilators
8.4. Portable Ventilators
8.5. Next Generation Ventilators
8.6. Kidney Dialysis
8.7. Surge Capacity Hospitals & ICUs
8.8. Extracorporeal Membrane Oxygenation Procedures
8.9. Others
9. BY MEDICAL ICT
9.1. Introduction
9.1.1. Market size analysis, and y-o-y growth analysis (%), By Medical ICT Segment
9.1.2. Market attractiveness index, By Medical ICT Segment
9.2. E-Health *
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
9.3. AI, Big Data & Deep Learning
9.4. Blockchain Technologies
9.5. Geo-Surveillance Systems & Services
9.6. Homecare IT
9.7. Others
10. BY PHARMA INDUSTRY PRODUCTS
10.1. Introduction
10.1.1. Market size analysis, and y-o-y growth analysis (%), By Pharma Industry Products Segment
10.1.2. Market attractiveness index, By Pharma Industry Products Segment
10.2. Vaccines*
10.2.1. Introduction
10.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
10.3. Therapeutic Drugs
10.4. Others
11. BY PERSONAL & PROTECTION GEAR
11.1. Introduction
11.1.1. Market size analysis, and y-o-y growth analysis (%), By Personal & Protection Gear Segment
11.1.2. Market attractiveness index, By Personal & Protection Gear Segment
11.2. Medical Gloves *
11.2.1. Introduction
11.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
11.3. Medical Face Masks
11.4. Medical PPE Gowns
11.5. Hand & Surface Sanitizers
11.6. Medical Face Shields
11.7. PPE Sterilization: Systems & Consumables
11.8. Medical Eye Protection
11.9. Others
12. BY COVID-19 RELATED MANUFACTURING PLANT
12.1. Introduction
12.1.1. Market size analysis, and y-o-y growth analysis (%), By COVID-19 Related Manufacturing Plant Segment
12.1.2. Market attractiveness index, By COVID-19 Related Manufacturing Plant Segment
12.2. Ventilators*
12.2.1. Introduction
12.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
12.3. Serologic Test Kits
12.4. Self-collection PCR Test Kits
12.5. PCR Reagents
12.6. PCR Systems
12.7. Gloves
12.8. PPE Gowns
12.9. Others
13. BY END-USER
13.1. Introduction
13.1.1. Market size analysis, and y-o-y growth analysis (%), By End-User Segment
13.1.2. Market attractiveness index, By End-User Segment
13.2. Hospitals*
13.2.1. Introduction
13.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
13.3. Emergency Medical Services (EMS)
13.4. Clinical Labs
13.5. Research Bodies
13.6. Homecare & Nursing Homes
13.7. Clinics
13.8. Others
14. BY REGION
14.1. Introduction
14.1.1. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Region
14.1.2. Market Attractiveness Index, By Region
14.2. North America
14.2.1. Introduction
14.2.2. Key region-specific dynamics
14.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Products and Services
14.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intensive Care Products & Services
14.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pharma Industry Products
14.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medical ICT
14.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Personal & Protection Gear
14.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By COVID-19 Related Manufacturing Plant
14.2.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
14.2.10. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
14.2.10.1. U.S.
14.2.10.2. Canada
14.2.10.3. Mexico
14.3. South America
14.3.1. Introduction
14.3.2. Key Region-Specific Dynamics
14.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Products and Services
14.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intensive Care Products & Services
14.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pharma Industry Products
14.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medical ICT
14.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Personal & Protection Gear
14.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By COVID-19 Related Manufacturing Plant
14.3.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
14.3.10. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
14.3.10.1. Brazil
14.3.10.2. Argentina
14.3.10.3. Rest of South America
14.4. Europe
14.4.1. Introduction
14.4.2. Key Region-Specific Dynamics
14.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Products and Services
14.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intensive Care Products & Services
14.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pharma Industry Products
14.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medical ICT
14.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Personal & Protection Gear
14.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By COVID-19 Related Manufacturing Plant
14.4.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
14.4.10. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
14.4.10.1. Germany
14.4.10.2. U.K.
14.4.10.3. France
14.4.10.4. Spain
14.4.10.5. Italy
14.4.10.6. Rest of Europe
14.5. Asia Pacific
14.5.1. Introduction
14.5.2. Key Region-Specific Dynamics
14.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Products and Services
14.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intensive Care Products & Services
14.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pharma Industry Products
14.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medical ICT
14.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Personal & Protection Gear
14.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By COVID-19 Related Manufacturing Plant
14.5.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
14.5.10. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
14.5.10.1. China
14.5.10.2. India
14.5.10.3. Japan
14.5.10.4. Australia
14.5.10.5. Rest of Asia Pacific
14.6. Middle East and Africa
14.6.1. Introduction
14.6.2. Key Region-Specific Dynamics
14.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Products and Services
14.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intensive Care Products & Services
14.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pharma Industry Products
14.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medical ICT
14.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Personal & Protection Gear
14.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By COVID-19 Related Manufacturing Plant
14.6.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
15. COMPETITIVE LANDSCAPE
15.1. Competitive scenario
15.2. Competitor strategy analysis
15.3. Market positioning/share analysis
15.4. Mergers and acquisitions analysis
16. COMPANY PROFILES
16.1. 3M Company*
16.1.1. Company Overview
16.1.2. Product Portfolio and Description
16.1.3. Key Highlights
16.1.4. Financial Overview
16.2. Abbott
16.3. Agilent Technologies
16.4. Medtronic
16.5. Pfizer
16.6. Qualaris Healthcare Solutions
16.7. Allscripts Healthcare Solutions
16.8. Agfa Healthcare
16.9. AbCellera
16.10. 3Scan
16.11. Sanofi
16.12. Advenio Technosys
16.13. Siemens
16.14. Amara Health Analytics
16.15. Regeneron Pharmaceuticals
16.16. Avalon
16.17. Eli Lilly
16.18. Merck
16.19. Koninklijke Philips NV(*List not Exhaustive*)
17. DATAM INTELLIGENCE
17.1. Appendix
17.2. About us and services
17.3. Contact us
